Get started
AbbVie Inc.AbbVie Inc.AbbVie Inc.

AbbVie Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with AbbVie Inc.



Key stats


Market capitalization
‪441.94 B‬ USD
Dividend yield (indicated)
2.77%
Price to earnings Ratio (TTM)
70.11
Basic EPS (TTM)
3.54 USD
Net income (FY)
‪4.19 B‬ USD
Revenue (FY)
‪61.16 B‬ USD
Shares float
‪1.76 B‬
Beta (1Y)
−0.48

Latest earnings


Last report date
Jul 31, 2026
Report period
Q2 2026
EPS
3.65 USD
Revenue
‪16.99 B‬ USD
Earnings call summary

Second quarter results exceeded expectations with double-digit revenue growth and raised full-year guidance. Immunology and neuroscience segments drove performance, while the Apogee acquisition and new product approvals strengthen the long-term outlook.

Employees


Employees (FY)
‪57 K‬
Change (1Y)
‪+2 K‬+3.64%
Revenue / Employee (1Y)
‪1.07 M‬ USD
Net income / Employee (1Y)
‪73.44 K‬ USD

Details


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Robert A. Michael
Website
abbvie.com
Headquarters
North Chicago
Founded
2011
IPO date
Jan 2, 2013
ISIN
US00287Y1091
CUSIP
00287Y109
FIGI
BBG0025Y4RY4
Identifiers
ISIN US00287Y1091
CFI code
ESVXFR
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


6.421% YTM
Maturity dateMar 15, 2035
Coupon4.55% (Fixed)
6.244% YTM
Maturity dateSep 15, 2066
Coupon6.10% (Fixed)
6.143% YTM
Maturity dateSep 15, 2056
Coupon6.00% (Fixed)
6.134% YTM
Maturity dateMar 15, 2064
Coupon5.50% (Fixed)
6.132% YTM
Maturity dateMar 15, 2066
Coupon5.65% (Fixed)
6.060% YTM
Maturity dateMar 15, 2054
Coupon5.40% (Fixed)
6.053% YTM
Maturity dateNov 21, 2049
Coupon4.25% (Fixed)
6.042% YTM
Maturity dateMar 15, 2056
Coupon5.55% (Fixed)
6.037% YTM
Maturity dateMay 14, 2046
Coupon4.45% (Fixed)
6.031% YTM
Maturity dateMar 15, 2055
Coupon5.60% (Fixed)
6.028% YTM
Maturity dateNov 14, 2048
Coupon4.88% (Fixed)

See all ABBV bonds 

ETFs holding the stock


VTI
Vanguard Morningstar Total Stock Market ETF
Weight0.61%
Market value‪14.12 B‬
VOO
Vanguard S&P 500 ETF
Weight0.69%
Market value‪11.55 B‬
IVV
iShares Core S&P 500 ETF
Weight0.66%
Market value‪5.97 B‬
SPY
SPDR S&P 500 ETF TRUST
Weight0.66%
Market value‪5.41 B‬
VTV
Vanguard Morningstar Value ETF
Weight1.66%
Market value‪4.23 B‬
XLV
State Street Health Care Select Sector SPDR ETF
Weight7.29%
Market value‪3.20 B‬
VIG
Vanguard Div Appreciation ETF
Weight1.93%
Market value‪2.51 B‬
VYM
Vanguard High Dividend Yield ETF
Weight1.84%
Market value‪1.78 B‬
VHT
Vanguard Health Care ETF
Weight6.54%
Market value‪1.34 B‬
DGRO
iShares Core Dividend Growth ETF
Weight2.89%
Market value‪1.26 B‬
SPYM
State Street SPDR Portfolio S&P 500 ETF
Weight0.66%
Market value‪1.12 B‬

Explore more ETFs 

Frequently asked questions


The current price of ABBV is 248.76 USD — it has increased by 0.85% in the past 24 hours. Watch AbbVie Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange AbbVie Inc. stocks are traded under the ticker ABBV.
ABBV stock has risen by 1.36% compared to the previous week, the month change is a −0.36% fall, over the last year AbbVie Inc. has showed a 25.58% increase.
We've gathered analysts' opinions on AbbVie Inc. future price: according to them, ABBV price has a max estimate of 300.00 USD and a min estimate of 230.00 USD. Watch ABBV chart and read a more detailed AbbVie Inc. stock forecast: see what analysts think of AbbVie Inc. and suggest that you do with its stocks.
ABBV reached its all-time high on Jul 29, 2026 with the price of 267.47 USD, and its all-time low was 32.51 USD and was reached on Dec 17, 2012. View more price dynamics on ABBV chart.
See other stocks reaching their highest and lowest prices.
ABBV stock is 1.86% volatile and has beta coefficient of −0.48. Track AbbVie Inc. stock price on the chart and check out the list of the most volatile stocks — is AbbVie Inc. there?
Today AbbVie Inc. has the market capitalization of ‪441.94 B‬, it has increased by 3.91% over the last week.
Yes, you can track AbbVie Inc. financials in yearly and quarterly reports right on TradingView.
AbbVie Inc. is going to release the next earnings report on Oct 23, 2026. Keep track of upcoming events with our Earnings Calendar.
ABBV earnings for the last quarter are 3.65 USD per share, whereas the estimation was 3.61 USD resulting in a 1.24% surprise. The estimated earnings for the next quarter are 3.86 USD per share. See more details about AbbVie Inc. earnings.
AbbVie Inc. revenue for the last quarter amounts to ‪16.99 B‬ USD, despite the estimated figure of ‪16.80 B‬ USD. In the next quarter, revenue is expected to reach ‪17.31 B‬ USD.
ABBV net income for the last quarter is ‪3.60 B‬ USD, while the quarter before that showed ‪685.00 M‬ USD of net income which accounts for 0.00% change. Track more AbbVie Inc. financial stats to get the full picture.
Yes, ABBV dividends are paid quarterly. The last dividend per share was 1.73 USD. As of today, Dividend Yield (TTM)% is 2.73%. Tracking AbbVie Inc. dividends might help you take more informed decisions.
AbbVie Inc. dividend yield was 2.91% in 2025, and payout ratio reached 281.66%. The year before the numbers were 3.54% and 263.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 13, 2026, the company has ‪57 K‬ employees. See our rating of the largest employees — is AbbVie Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AbbVie Inc. EBITDA is ‪29.92 B‬ USD, and current EBITDA margin is 47.50%. See more stats in AbbVie Inc. financial statements.
Like other stocks, ABBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AbbVie Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AbbVie Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AbbVie Inc. stock shows the buy signal. See more of AbbVie Inc. technicals for a more comprehensive analysis.